Page last updated: 2024-10-27

flumazenil and Cerebral Pseudosclerosis

flumazenil has been researched along with Cerebral Pseudosclerosis in 2 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, EA1
Weissenborn, K1
Todorov, T1
Savov, A1
Mihaylova, V1
Buettner, J1
Koseva, O1
Krustev, Z1
Jelev, H1
Tournev, I1
Penkov, V1
Konstantinova, D1
Tankova, L1
Tzolova, N1
Kremensky, I1
Schmidt, H1

Reviews

1 review available for flumazenil and Cerebral Pseudosclerosis

ArticleYear
Neurology and the liver.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:3

    Topics: Ammonia; Brain Edema; Cholestasis; Diagnosis, Differential; Fatigue; Flumazenil; GABA Modulators; He

1997

Other Studies

1 other study available for flumazenil and Cerebral Pseudosclerosis

ArticleYear
Ethnic specific background of mutations in Bulgarian patients with Wilson disease.
    Genetic counseling (Geneva, Switzerland), 2007, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Age of Onset; Alleles; Bulgaria; Ethnicity; Gene Expression; Haplotypes; Hepatole

2007